0

Journal Articles

in Drug Therapy
 41-60 of 342 Articles
Original Contribution |  February 13, 2013
Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections:  The ESTABLISH-1 Randomized Trial
Philippe Prokocimer, MD; Carisa De Anda, PharmD; Edward Fang, MD; et al.
JAMA. 2013;309(6):559-569. doi:10.1001/jama.2013.241.
INCLUDES: , Supplemental Content
Original Contribution |  February 13, 2013
Risk of Recurrent Helicobacter pylori Infection 1 Year After Initial Eradication Therapy in 7 Latin American Communities
Douglas R. Morgan, MD, MPH; Javier Torres, PhD; Rachael Sexton, MS; et al.
JAMA. 2013;309(6):578-586. doi:10.1001/jama.2013.311.
INCLUDES: , Supplemental Content
From the Centers for Disease Control and Prevention |  February 13, 2013
Buprenorphine Prescribing Practices and Exposures Reported to a Poison Center—Utah, 2002-2011
JAMA. 2013;309(6):536-538. doi:10.1001/jama.2012.217206.
Editorial |  February 06, 2013
Medications for Improving Walking Performance in Peripheral Artery Disease:  Still Miles to Go
Mary McGrae McDermott, MD
JAMA. 2013;309(5):487-488. doi:10.1001/jama.2013.89.
JAMA Clinical Evidence Synopsis |  February 06, 2013
Opioid Analgesics for Rheumatoid Arthritis Pain
Samuel L. Whittle, MBBS, MClinEpi; Bethan L. Richards, MBBS, MClinEpi; Rachelle Buchbinder, MBBS, PhD
JAMA. 2013;309(5):485-486. doi:10.1001/jama.2012.193412.
Lab Reports |  February 06, 2013
Safer Cancer Drug
Tracy Hampton, PhD
JAMA. 2013;309(5):431. doi:10.1001/jama.2013.269.
Medical News and Perspectives |  February 06, 2013
MDR-TB Has New Drug Foe After Fast-Track Approval
Rebecca Voelker, MSJ
JAMA. 2013;309(5):430. doi:10.1001/jama.2013.94.
Viewpoint |  February 06, 2013
FDA Regulation of Off-label Drug Promotion Under Attack
Aaron S. Kesselheim, MD, JD, MPH; Michelle M. Mello, JD, PhD, MPhil; Jerry Avorn, MD
JAMA. 2013;309(5):445-446. doi:10.1001/jama.2012.207972.
Clinical Crossroads |  February 06, 2013
Management of Transgenderism
Norman P. Spack, MD
JAMA. 2013;309(5):478-484. doi:10.1001/jama.2012.165234.
INCLUDES: CME
Health Agencies Update |  January 23, 2013
Telaprevir Warning
Bridget M. Kuehn, MSJ
JAMA. 2013;309(4):333. doi:10.1001/jama.2013.22.
Health Agencies Update |  January 23, 2013
Varenicline Safety Notice
Bridget M. Kuehn, MSJ
JAMA. 2013;309(4):333. doi:10.1001/jama.2013.16.
Medical News and Perspectives |  January 23, 2013
Researchers Seek New Ways to Counter the Harmful Toll of Stress on the Brain
M. J. Friedrich
JAMA. 2013;309(4):330-332. doi:10.1001/jama.2012.174455.
Caring for the Critically Ill Patient |  January 09, 2013
Effect of Intravenous Paracetamol on Postoperative Morphine Requirements in Neonates and Infants Undergoing Major Noncardiac Surgery:  A Randomized Controlled Trial
Ilse Ceelie, MD, PhD; Saskia N. de Wildt, MD, PhD; Monique van Dijk, MSc, PhD; et al.
JAMA. 2013;309(2):149-154. doi:10.1001/jama.2012.148050.
Editorial |  January 09, 2013
Pain Panacea for Opiophobia in Infants?
Kanwaljeet J. S. Anand, MBBS, DPhil, FRCPCH
JAMA. 2013;309(2):183-184. doi:10.1001/jama.2012.208359.
Editorial |  January 09, 2013
Cephalosporin-Resistant Gonorrhea in North America
Robert D. Kirkcaldy, MD, MPH; Gail A. Bolan, MD; Judith N. Wasserheit, MD, MPH
JAMA. 2013;309(2):185-187. doi:10.1001/jama.2012.205107.
Lab Reports |  January 02, 2013
Cancer Drug Resistance
Tracy Hampton, PhD
JAMA. 2013;309(1):20. doi:10.1001/jama.2012.173440.
Medical News and Perspectives |  December 26, 2012 FREE
Unsafe Injection Practices Plague US Outpatient Facilities, Harm Patients
Bridget M. Kuehn, MSJ
JAMA. 2012;308(24):2551-2552. doi:10.1001/jama.2012.114239.
Special Communication |  December 26, 2012 FREE
Reporting of Noninferiority and Equivalence Randomized Trials:  Extension of the CONSORT 2010 Statement
Gilda Piaggio, PhD; Diana R. Elbourne, PhD; Stuart J. Pocock, PhD; et al.
JAMA. 2012;308(24):2594-2604. doi:10.1001/jama.2012.87802.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  December 19, 2012
Zolpidem Increases Patients’ Fall Risk, Study Shows
Rebecca Voelker, MSJ
JAMA. 2012;308(23):2447. doi:10.1001/jama.2012.128004.
Original Contribution |  December 19, 2012
Long-term Use of Aspirin and Age-Related Macular Degeneration
Barbara E. K. Klein, MD, MPH; Kerri P. Howard, MS; Ronald E. Gangnon, PhD; et al.
JAMA. 2012;308(23):2469-2478. doi:10.1001/jama.2012.65406.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Developing a Model for Attending Physician Workload and Outcomes
Henry J. Michtalik, MD, MPH, MHS; Peter J. Pronovost, MD, PhD; Jill A. Marsteller, PhD, MPP; et al.
JAMA Internal Medicine
Viewpoint  |  March 25, 2013
Surrogate Outcomes in Clinical Trials:  A Cautionary Tale
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Internal Medicine
Invited Commentary  |  February 4, 2013
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems